BioSpace News Archive

On a beautiful Orange County morning, Avanir Pharmaceuticals, Inc. joined the nonprofit Alzheimer’s Orange County to raise awareness and funds to fight Alzheimer’s and dementia

Dr. Lotto has published and presented research on vascular surgery and other topics in medical journals and at regional and national conferences.

Featuring pioneers in molecular biology, inaugural lecture to take place on November 20th, 2019.

A better solution must be found: 95% of the doctors participating in the Frost & Sullivan marketing survey, admitted that currently available pessaries and surgery are not satisfactory treatments for POP, mainly because of side effects from pessary usage and associated complications of surgery

ConvenientMD is an all-inclusive solution for treating a broad range of injuries and illnesses, led by the area’s leading physicians and providers.

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Lipocine Inc. and certain of its officers, on behalf of shareholders who purchased Lipocine securities purchased between March 27, 2019, and November 8, 2019, both dates inclusive.

Group of seven new attorneys arrive with substantial patent and regulatory expertise to address legal issues related to dietary supplements and CBD

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional independent member.

Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the closing of a public offering of (i) 10,450,000 Class A Units, each consisting of shares of its common stock and common warrants to purchase its common stock and (ii) 1,550,000 Class B Units consisting of pre-funded warrants and warrants to purchase its common stock

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21 at 4:40 p.m. GMT in London, UK.